Categories
Blog Law / Litigation ZeroMandatoryVaxx

New York City Judge Rules NYPD CV-19 Vaxx Mandate Is Invalid

September 23, 2022 | Image Source

September 23, 2022 | A huge victory was handed down in New York City where the judge ruled that police officers can’t be fired for refusing the CV-19 vaxx.  The judged ordered that NYPD officers who were fired for refusing to take the jab be reinstated to their positions. All vaxx mandates need to end.  -JD

 


Judge rules NYC vaxx mandate for NYPD is invalid

Link To Video


 

 

 

Categories
Blog ZeroMandatoryVaxx

New Harvard Study Indicates Jab More Dangerous than CV-19

September 23, 2022 | Author’s conclusion characterize vaxx mandates as, “severe infringements of individual liberty” that are “ethically unjustifiable.”  

A recent pre-print study conducted by researchers from Harvard and Johns Hopkins argues against vaxx mandates especially for young people. Their findings reveal that serious adverse events are to be expected.

The CDC, an agency collaborating with China for the last 30 years, has consistently provided the public with false information. It’s time to stop following the advice of corrupt alphabet agencies and #StopTheShots immediately. -JD

 


 

September 14, 2022 | By JONAS VESTERBERGThe Florida Standard

CDC Director Rochelle Walensky has also stated that the boosters must be expedited in order to work properly. A delay would potentially render the shots “outdated” as new variants would form, Walensky argues.

STUDY: WORSE THAN THE VIRUS

A new study conducted by scientists from Harvard and Johns Hopkins, currently in pre-print, reveals that the COVID-19 vaccines were up to 98 times worse than the virus itself. The study is critical of the booster requirement for American university students, stating in the abstract: “Using CDC and sponsor-reported adverse event data, we find that booster mandates may cause a net expected harm: per COVID-19 hospitalisation prevented in previously uninfected young adults, we anticipate 18 to 98 serious adverse events, including 1.7 to 3.0 booster-associated myocarditis cases in males, and 1,373 to 3,234 cases of grade ≥3 reactogenicity which interferes with daily activities.”

Link To Full Article HERE

 


 

Covid-19 vaccine boosters for young adults: A risk-benefit assessment and five ethical arguments against mandates at universities_Link To Preprint Article 

 

Link To Preprint Article_Covid-19 vaccine boosters for young adults- A risk-benefit assessment and five ethical arguments against mandates at universities 


 

Categories
Blog Freedom Law / Litigation ZeroMandatoryVaxx

Victory! Biden administration’s Head Start Mask & V@xx Mandate Struck Down by Federal Judge

“Jab-or-job” mandate defeated

September 21, 2022 |  Link To Memorandum Ruling

Source:  https://libertyjusticecenter.org/media/head-start/

A Federal U.S. District Judge from Louisiana, Terry A. Doughty, struck down the Biden administration’s mandate requiring Staff at Head Start child care facilities to wear masks and be injected with the experimental CV-19 jab. Doughty issued a permanent injection ruling that the plaintiffs faced a “substantial threat of irreparable injury” if the mandate wasn’t struck down.

The rule requiring masking and experimental injections was issued in November 2021 by the Department of Health and Human Services, the Office of Head Start, and the Administration for Children and Families. All Staff and children over the age of two were subjected to these harmful measures.

24 state governments were plaintiffs in the case, from the states of Alabama, Alaska, Arizona, Arkansas, Florida, Georgia, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, North Dakota, South Dakota, Ohio, Oklahoma, South Carolina, Tennessee, Utah, West Virginia, and Wyoming.

-JD


 

Link To Article_FEDERAL JUDGE STRIKES DOWN FEDERAL SCHOOL MASK AND VACCINE MANDATE

 

Link To Article_Federal judge strikes down Biden administration’s Head Start vaccine, mask mandate 

 


 

Categories
Biowarfare Blog ZeroMandatoryVaxx

Presence of graphene-based carbon nanotubes in Pfizer v@xx

La Quinta Columna researcher, Ricardo Delgado Martín, presents optical microscope analysis of the Comirnaty Pfizer injectable. The magnification, up to 2000x, reveals self- assembling carbon nanotubes, graphene oxide, glowing nano particles and other debris.

Martín explains the role of microwave radiation in activating graphene oxide and other v@xx components. Sharp edges of graphene oxide and long carbon nano tubes illustrate the potential cause of catastrophic injuries and deaths that have resulted from these hazardous materials in the bloodstream. -JD

**Rice University was researching ‘teslaphoresis‘ or self assembly of nanotubes at a distance, in 2016.


September 16, 2022 | By Ricardo Delgado Martín | La Quinta Columna

 

Link To Video

Link To Video at Bitchute


September 5, 2022 | By  |

Pablo Campra, PhD in Chemical Sciences, and Degree in Biological Sciences, identified and evidenced the existence of graphene in Pfizer, Moderna, Astrazeneca and Janssen vaccines.

Link To Video

Download the Campra report:  https://www.laquintacolumna.info/docs/docs/campra-informe-tecnico-en.pdf


April 14, 2016 | Rice University | Carbon nanotubes self-assemble

LINK


“The novel coronavirus vaccine contains graphene oxide”

Chinese Patent CN112220919A CV Vaxx contains graphene oxide 

Link


 

2015 study discusses potential to implant nano sensors into human organs to function as part of a wireless nanosensor network (WNSN) to possibly be used for intrabody disease detection. The article states that, “nanosensors deployed in WNSN, equipped with graphene-based nanopatch antennas [3], can detect symptoms or virus by means of molecules [7] or bacteria behaviors [8]. In fact, the large surface area and the excellent electrical conductivity of graphene allow rapid electron transfer that facilitates accurate and selective detection of biomolecules.”

Design of Wireless Nanosensor Networks for Intrabody Application

Link


 

3D Reduced Graphene Oxide/Sio 2 Composite For Ice Nucleation 

US Patent 2022/0002159 A1 | The present invention relates to the field of cloud seeding.

3D Graphene Oxide Nanoparticles for Cloud Seeding Patent US 2022/0002159 A1

LINK

 


 

Categories
Blog ZeroMandatoryVaxx

Study: Ivermectin Led to a 92% Reduction in COVID-19 Mortality Rate

Study: Ivermectin Led to a 92% Reduction in COVID-19 Mortality Rate

A recent peer reviewed study by authors, Kerr L, Baldi F, Lobo R, et al. (August 31, 2022), demonstrated that ivermectin used as prophylaxis effectively reduced infection, hospitalization, and mortality rates for CV-19 by 92%.

The Emergency Use Authorization for the experimental warp speed jab could not have lawfully been approved if  preventative treatments such as Ivermectin and HCQ were readily available. These cures were suppressed and those who questioned the official narrative were ridiculed and punished. A pandemic, lockdowns, closed businesses, masks, distancing — none of the covid theatre was necessary. Millions could have been spared injury, suffering and death by the unsafe CV-19 jab.

The injections must be halted immediately and those responsible prosecuted. -JD

 


 

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Authors:

Conclusion

 

Non-use of ivermectin was associated with a 12.5-fold increase in mortality rate and a seven-fold increased risk of dying from COVID-19 compared to the regular use of ivermectin. This dose-response efficacy reinforces the prophylactic effects of ivermectin against COVID-19.

 

Introduction

Ivermectin has been proposed as potential prophylaxis and therapy for coronavirus disease 2019 (COVID-19) due to its previously reported anti-viral [1-4], metabolic [5-10], and anti-inflammatory [11-19] actions, with strong plausibility [20,21] and positive in vitro, in vivo, and epidemiological findings [22-24] in preliminary studies.

Between July and December 2020, a citywide program in Itajaí, in the state of Santa Catarina, Southern Brazil, offered a voluntary, medically prescribed program of ivermectin as prophylaxis for COVID-19. This was based on the extensive, well-established safety profile and known absence of risks with long-term use of ivermectin, and the lack of therapeutic and preventive alternative options in 2020.

The systematically collected data within this program demonstrated that ivermectin used as prophylaxis for COVID-19 improved COVID-19 related-outcomes. The use of ivermectin led to a 44% reduction in infection rate, a 56% reduction in hospitalization rate, and a 68% reduction in mortality rate by using propensity score matching (PSM) to balance the study groups [25].

These conclusions were based on an analog evaluation of the intent-to-treat (ITT) analysis of randomized clinical trials (RCTs). All participants of the program were included for analysis, irrespective of regularity or the total amount of ivermectin taken. Among participants of the ivermectin use (regular and irregular) as prophylaxis for the COVID-19 program, it was unknown if regular ivermectin use would lead to a more substantial reduction in COVID-19 infection rate and related outcomes than irregular use.

In this study, an evaluation was done with participants that used ivermectin prophylactically for COVID-19, to determine if regular use compared to irregular use impacted the degree of reduction in COVID-19 infection, hospitalization, and mortality rates. Regular and irregular ivermectin users were also compared to non-users to evaluate evidence of a dose-response pattern of efficacy.

 

Link To Article HERE